Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-19 4:02 pm Purchase | 2021-11-18 | 13G | Cardiff Oncology, Inc. CRDF | PFIZER INC PFE | 2,411,575 5.750% | 2,411,575 (New Position) | Filing History |
| 2021-09-20 4:25 pm Purchase | 2021-09-13 | 13G | Arvinas, Inc. ARVN | PFIZER INC PFE | 3,457,815 6.600% | 3,457,815 (New Position) | Filing History |
| 2021-09-17 4:27 pm Unchanged | 2021-09-10 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 18.900% | 0 (Unchanged) | Filing History |
| 2021-09-17 4:17 pm Unchanged | 2021-09-10 | 13D | Allogene Therapeutics, Inc. ALLO | PFIZER INC PFE | 22,032,040 15.500% | 0 (Unchanged) | Filing History |
| 2021-07-09 4:25 pm Purchase | 2021-06-30 | 13G | Spero Therapeutics, Inc. SPRO | PFIZER INC PFE | 2,362,348 7.370% | 2,362,348 (New Position) | Filing History |
| 2021-07-09 4:16 pm Unchanged | 2021-07-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 19.400% | 0 (Unchanged) | Filing History |
| 2021-03-25 4:17 pm Sale | 2021-03-16 | 13G | Quince Therapeutics, Inc. QNCX | PFIZER INC PFE | 2,056,377 7.000% | -86,995 (-4.06%) | Filing History |
| 2021-02-12 6:37 pm Purchase | 2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | PFIZER INC PFE | 1,666,658 6.300% | 1,666,658 (New Position) | Filing History |
| 2021-02-12 6:00 pm Purchase | 2020-12-31 | 13G | BioAtla, Inc. BCAB | PFIZER INC PFE | 2,238,090 7.000% | 2,238,090 (New Position) | Filing History |
| 2021-02-12 5:37 pm Sale | 2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX | PFIZER INC PFE | 2,143,372 7.300% | -1,106,601 (-34.05%) | Filing History |
| 2021-02-12 5:17 pm Purchase | 2020-12-31 | 13G | ContraFect Corporation CFRX | PFIZER INC PFE | 22,316 6.400% | 22,316 (New Position) | Filing History |
| 2021-02-12 5:08 pm Sale | 2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX | PFIZER INC PFE | 4,583,047 9.400% | -10,800 (-0.24%) | Filing History |
| 2021-02-12 4:31 pm Sale | 2020-12-31 | 13G | Pfizer Inc. PFE | STATE STREET CORP STT | 279,831,373 5.030% | -28,599,376 (-9.27%) | Filing History |
| 2021-02-12 4:28 pm Sale | 2020-12-31 | 13G | Morphic Holding, Inc. MORF | PFIZER INC PFE | 1,265,635 4.100% | -1,263,200 (-49.95%) | Filing History |
| 2021-02-12 4:17 pm Sale | 2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN | PFIZER INC PFE | 0 0.000% | -2,209,631 (Position Closed) | Filing History |
| 2021-02-10 11:40 am Sale | 2020-12-31 | 13G | Pfizer Inc. PFE | VANGUARD GROUP INC | 447,958,747 8.060% | -26,298,281 (-5.55%) | Filing History |
| 2021-01-29 5:22 pm Sale | 2020-12-31 | 13G | Pfizer Inc. PFE | BlackRock Inc. BLK | 396,973,512 7.100% | -52,271,179 (-11.64%) | Filing History |
| 2020-11-19 4:13 pm Purchase | 2020-11-10 | 13G | Homology Medicines, Inc. FIXX | PFIZER INC PFE | 277,778 9.900% | 277,778 (New Position) | Filing History |
| 2020-11-06 4:10 pm Purchase | 2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE | PFIZER INC PFE | 27,349,211 21.500% | 27,349,211 (New Position) | Filing History |
| 2020-08-06 4:22 pm Purchase | 2020-07-31 | 13G | ESSA Pharma Inc. EPIX | PFIZER INC PFE | 1,675,000 6.000% | 1,675,000 (New Position) | Filing History |